CN103301266B - 一种治疗前列腺肥大的中药 - Google Patents
一种治疗前列腺肥大的中药 Download PDFInfo
- Publication number
- CN103301266B CN103301266B CN201310171343.XA CN201310171343A CN103301266B CN 103301266 B CN103301266 B CN 103301266B CN 201310171343 A CN201310171343 A CN 201310171343A CN 103301266 B CN103301266 B CN 103301266B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- treating
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title abstract description 5
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title abstract description 5
- 210000002307 prostate Anatomy 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 235000000421 Lepidium meyenii Nutrition 0.000 claims description 8
- 240000000759 Lepidium meyenii Species 0.000 claims description 8
- 235000012902 lepidium meyenii Nutrition 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 206010020718 hyperplasia Diseases 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 239000002775 capsule Substances 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 239000000843 powder Substances 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 238000003756 stirring Methods 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 208000031971 Yin Deficiency Diseases 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 description 11
- 238000011282 treatment Methods 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 6
- 208000006750 hematuria Diseases 0.000 description 5
- 206010020880 Hypertrophy Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010046555 Urinary retention Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- ZZIZZTHXZRDOFM-UHFFFAOYSA-N 2-(2-ethoxyphenoxy)ethyl-[1-(4-methoxy-3-sulfamoylphenyl)propan-2-yl]azanium;chloride Chemical compound Cl.CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 ZZIZZTHXZRDOFM-UHFFFAOYSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- DRHKJLXJIQTDTD-OAHLLOKOSA-N Tamsulosine Chemical compound CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 DRHKJLXJIQTDTD-OAHLLOKOSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960002613 tamsulosin Drugs 0.000 description 1
- 229960003198 tamsulosin hydrochloride Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明治疗前列腺肥大的中药是由以下重量份数的原料药：益母草10～15份、牛膝20～25份、当归10～15份、黄芪5～10份、柴胡3～5份、菟丝子3～5份、生地8～12份、泽泻15～20份、玛卡8～15份制成。本发明中药的制备方法是将各种原料药粉碎为100目以上的粉末，搅拌均匀后装入胶囊中制成胶囊剂。每粒胶囊装药量0.3克。服用方法为早晚各服6粒，温开水服用。本发明滋阴养血，调补肝肾，通络活血，泄热通淋；治疗前列腺肥大引起的各种不适效果显著。
Description
技术领域
本发明属于中药制备技术领域，具体涉及一种治疗前列腺肥大的中药。
背景技术
前列腺肥大是人体在性激素平衡失调等因素作用下，引起后尿道粘膜下的中叶或倒叶的腺体结缔组织及平滑肌组织逐渐增生，而形成多发性球状结节，使尿道、膀胱和肾脏发生一系列功能紊乱的疾病。前列腺增生肥大的症状表现为：1、排尿无力、尿线变细和尿滴沥：由于增生前列腺将尿道压瘪致尿线变细，患者排尿要使用更大的力气克服阻力，随着病情的发展，还可能出现排尿中断，排尿后滴沥不尽等症状。 2、尿潴留：前列腺增生较重的晚期患者，梗阻严重时可因受凉、饮酒、憋尿时间过长或感染等原因导致尿液无法排出而发生急性尿潴留。3、血尿: 尿液中带血即为血尿，又称尿血。正常情况下，尿液中是没有红细胞的。医学上把病人尿液离心沉淀后，用显微镜来检查，如果每个高倍视野中有5 个以上的红细胞，就叫血尿。西医多用盐酸坦索罗辛缓释胶囊、非那司提片等治疗，中医多治以补肾助阳、清热利湿、活血化瘀等。
发明内容
本发明的目的是提供一种治疗前列腺肥大的中药。
本发明治疗前列腺肥大的中药是由以下重量份数的原料药：益母草10～15份、牛膝20～25份、当归10～15份、黄芪5～10份、柴胡3～5份、菟丝子3～5份、生地8～12份、泽泻15～20份、玛卡8～15份制成。
优选地，本发明可以由以下重量份数的原料药：益母草12份、牛膝22份、当归13份、黄芪8份、柴胡4份、菟丝子4份、生地10份、泽泻17份、玛卡11份制成。
本发明中药的制备方法是将各种原料药粉碎为100目以上的粉末，搅拌均匀后装入胶囊中制成胶囊剂。每粒胶囊装药量0.3克。服用方法为早晚各服6粒，温开水服用。
本发明中药组方中，当归补血活血，调经止痛，润肠通便，用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。玛卡含较高量的铁，蛋白质、氨基酸、矿物质锌、牛磺酸等成分能明显对抗疲劳，增强肌肉耐力，抵抗运动性疲劳，帮助坚固免疫系统，提升机体抗病力，对抗疲劳，增强精力、体力，改善贫血症状。菟丝子补肾益精，养肝明目，健脾固胎，用于腰痛耳鸣，阳痿遗精，消渴，不育，遗尿失禁，淋浊带下，头目昏暗，食少泄泻，胎动不安。益母草活血、祛淤、调经、消水。治疗妇女月经不调，胎漏难产，胞衣不下，产后血晕，瘀血腹痛，崩中漏下，尿血、泻血，痈肿疮疡。牛膝活血通经；引火（血）下行；利尿通淋。牛膝主治腰膝酸痛；下肢痿软；血滞经闭；痛经；产后血瘀腹痛；症瘕；胞衣不下；热淋；血淋；跌打损伤；痈肿恶疮；咽喉肿痛。黄芪有益气固表、敛汗固脱、托疮生肌、利水消肿之功效，用于治疗气虚乏力，中气下陷，久泻脱肛，便血崩漏，表虚自汗，痈疽难溃，久溃不敛，血虚萎黄，内热消渴，慢性肾炎，蛋白尿，糖尿病等。柴胡透表泄热，疏肝解郁，升举阳气；主治：感冒发热、寒热往来、疟疾，肝郁气滞，胸肋胀痛，脱肛，子宫脱落，月经不调。生地清热、生津、润燥、滑肠、破瘀、生新、止痛、调经、金疮瘀、凉血、止血。泽泻利水渗湿；泄热通淋，主小便不利；热淋涩痛；水肿胀满；泄泻；痰饮眩晕；遗精。诸药配伍，滋阴养血，调补肝肾，通络活血，泄热通淋；治疗前列腺肥大引起的各种不适效果显著。
有关临床资料如下：
70例病例中，年龄最大75岁，最小28岁，均经肛门指检、B超等临床检查诊断确诊，B超检查:轻度肥大29例，中度肥大26例，重度肥大15例。残余尿<100mL者28例，100～200mL者25例，201～250mL者15例；留置导尿管者2例。
诊断标准：依据《前列腺病中医诊疗学》，症状：尿频，排尿等待而难出，尿流细，夜尿频多，尿后余沥不尽。肛门指诊：可触及增生的前列腺，表面光滑，质地较硬，中央沟消失，个别触及有压痛。彩超检查提示前列腺不同程度增生。
治疗方法：早晚各服用6粒0.3克胶囊，温开水服用。
疗效评定：参考国家中医药管理局1994 年发布的《中医病证诊断疗效标准》拟定。显效：小便通畅，临床症状及体征消失；好转：临床症状及体征改善；无效：临床症状无改善。
病例治疗后疗效统计结果如下：
| 组别 | 例数 | 显效（n%） | 好转（n%） | 无效（n%） | 总有效率（n%） |
| 治疗组 | 70 | 45（64.3%） | 20（28.6%） | 5（7.1%） | 92.9% |
具体实施方式
下面给出的实施例拟对本发明作进一步说明，但不能理解为是对本发明保护范围的限制，本领域技术人员根据本发明内容对本发明的一些非本质的改进和调整，仍属于本发明的保护范围。
实施例1
选取益母草10克、牛膝20克、当归10克、黄芪5克、柴胡3克、菟丝子3克、生地8克、泽泻15克、玛卡8克，将各种药材粉碎为100目以上的粉末，搅拌均匀后按照0.3克一粒装入胶囊。服用时早晚各6粒，温开水服用。
实施例2
选取益母草15克、牛膝25克、当归15克、黄芪10克、柴胡5克、菟丝子5克、生地12克、泽泻20克、玛卡15克，将各种药材粉碎为100目以上的粉末，搅拌均匀后按照0.3克一粒装入胶囊。服用时早晚各6粒，温开水服用。
实施例3
选取益母草12克、牛膝22克、当归13克、黄芪8克、柴胡4克、菟丝子4克、生地10克、泽泻17克、玛卡11克，将各种药材粉碎为100目以上的粉末，搅拌均匀后按照0.3克一粒装入胶囊。服用时早晚各6粒，温开水服用。
Claims (2)
1.一种治疗前列腺肥大的中药，其特征在于是由以下重量份数的原料药：益母草10～15份、牛膝20～25份、当归10～15份、黄芪5～10份、柴胡3～5份、菟丝子3～5份、生地8～12份、泽泻15～20份、玛卡8～15份制成。
2.根据权利要求1所述的中药，其特征在于是由以下重量份数的原料药：益母草12份、牛膝22份、当归13份、黄芪8份、柴胡4份、菟丝子4份、生地10份、泽泻17份、玛卡11份制成。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310171343.XA CN103301266B (zh) | 2013-05-11 | 2013-05-11 | 一种治疗前列腺肥大的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310171343.XA CN103301266B (zh) | 2013-05-11 | 2013-05-11 | 一种治疗前列腺肥大的中药 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103301266A CN103301266A (zh) | 2013-09-18 |
| CN103301266B true CN103301266B (zh) | 2015-04-15 |
Family
ID=49127272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310171343.XA Expired - Fee Related CN103301266B (zh) | 2013-05-11 | 2013-05-11 | 一种治疗前列腺肥大的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103301266B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105412837A (zh) * | 2015-12-21 | 2016-03-23 | 孙红霞 | 一种治疗前列腺肥大的药物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843787A (zh) * | 2009-10-28 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
| CN102240320A (zh) * | 2011-07-04 | 2011-11-16 | 河南中医学院 | 一种治疗前列腺增生的益芪胶囊 |
| CN102526428A (zh) * | 2012-02-21 | 2012-07-04 | 简福川 | 一种治疗前列腺增生的中药 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20100082A1 (es) * | 2008-05-08 | 2010-02-17 | Univ Peruana Cayetano Heredia | Desarrollo de 4 sachets de extractos acuosos o hidroalcoholicos de maca negra y de maca roja |
-
2013
- 2013-05-11 CN CN201310171343.XA patent/CN103301266B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843787A (zh) * | 2009-10-28 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
| CN102240320A (zh) * | 2011-07-04 | 2011-11-16 | 河南中医学院 | 一种治疗前列腺增生的益芪胶囊 |
| CN102526428A (zh) * | 2012-02-21 | 2012-07-04 | 简福川 | 一种治疗前列腺增生的中药 |
Non-Patent Citations (1)
| Title |
|---|
| 秘鲁特产药用植物玛卡研究的新进展;肖伟等;《世界科学技术-中医药现代化》;20071231;第9卷(第3期);第102-106页，尤其是第104页左栏第3段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103301266A (zh) | 2013-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101912585B (zh) | 一种治疗子宫肌瘤的药物及其制备方法 | |
| CN103599472B (zh) | 一种用于治疗前列腺增生的中药组合物 | |
| CN1895434B (zh) | 一种治疗子宫肌瘤的药物 | |
| CN101195011B (zh) | 一种治疗前列腺炎、增生的中药 | |
| CN103301266B (zh) | 一种治疗前列腺肥大的中药 | |
| CN101700390B (zh) | 一种内服治疗脂肪肝的中药组合物 | |
| CN103705876A (zh) | 一种治疗小儿遗尿症的中药汤剂 | |
| CN103655845A (zh) | 一种治疗子宫脱垂的中药组合物 | |
| CN103301305A (zh) | 一种用于治疗前列腺肥大的中药 | |
| CN102846744B (zh) | 一种治疗前列腺肥大的药物 | |
| CN105031505A (zh) | 一种治疗良性前列腺增生肥大的药物及其制备方法 | |
| CN101371900A (zh) | 一种内服治疗便秘的中药组合物 | |
| CN103656063A (zh) | 用于治疗慢性前列腺炎的药物 | |
| CN104740496A (zh) | 一种治疗直肠癌的中药组合物 | |
| CN103599240A (zh) | 一种治疗多囊性卵巢综合征的口服液 | |
| CN103585575B (zh) | 一种用于胆结石及前列腺增生的中药组合物 | |
| CN104721638A (zh) | 一种用于治疗前列腺炎的中药制剂 | |
| CN105412837A (zh) | 一种治疗前列腺肥大的药物 | |
| CN105688056A (zh) | 一种治疗泌尿系结石的药物及其制备方法 | |
| CN104383417A (zh) | 一种治疗乳腺癌的药物 | |
| CN104352950A (zh) | 一种治疗妇科炎症的中药组合物 | |
| CN104587420A (zh) | 一种治疗儿童遗尿症的中药汤剂 | |
| CN103127352B (zh) | 一种治疗血瘀型月经不调的中药组合物 | |
| CN103948719A (zh) | 复方毛冬青灌肠液及其制备方法 | |
| CN104013866A (zh) | 一种治疗盆腔炎的中药口服液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: SECOND HOSPITAL OF SHANXI MEDICAL UNIVERSITY Free format text: FORMER OWNER: LIU YUEZE Effective date: 20150311 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Yueze Inventor after: Fang Zhenhuan Inventor after: Wang Xiangli Inventor after: Li Shaogang Inventor after: Zhang Di Inventor before: Liu Yueze |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU YUEZE TO: LIU YUEZE FANG ZHENHUAN WANG XIANGLI LI SHAOGANG ZHANG DI Free format text: CORRECT: ADDRESS; FROM: 042400 LINFEN, SHAANXI PROVINCE TO: 030000 TAIYUAN, SHAANXI PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150311 Address after: 030000 No. 382 Wuyi Road, Shanxi, Taiyuan, China Applicant after: The Second Hospital of Shanxi Medical University Address before: Shanxi city of Linfen Province, Beijing village 042400 ancient town of Peking Applicant before: Liu Yueze |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150415 Termination date: 20200511 |